- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12.25 | Glenmark Pharma's US arm launches Epinephrine Injection in American market | 5 | capitalmarket.com | ||
| 22.12.25 | Glenmark Pharmaceuticals Ltd up for third consecutive session | 7 | capitalmarket.com | ||
| GLENMARK PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | Glenmark Pharma's U.S. arm to launch Leucovorin Calcium Injection in the U.S. Market | 5 | capitalmarket.com | ||
| 01.12.25 | Glenmark Pharmaceuticals: Cosmo and Glenmark Announce Market Authorisation of Winlevi (clascoterone) 10 mg/g cream for Treatment of Acne in 17 countries in Europe | 828 | PR Newswire | DUBLIN and MUMBAI, India, Dec. 1, 2025 /PRNewswire/ -- Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), announced that the European Commission... ► Artikel lesen | |
| 01.12.25 | Glenmark Pharma's Chhatrapati Sambhajinagar facility clears USFDA inspection with zero observations | 4 | capitalmarket.com | ||
| 27.11.25 | Drugmaker Glenmark Pharma Receives Establishment Inspection Report From US Health Regulator For Formulations Manufacturing Facility In North Carolina | 3 | The Free Press Journal | ||
| 27.11.25 | Glenmark Pharmaceuticals Ltd up for third straight session | 2 | capitalmarket.com | ||
| 27.11.25 | Glenmark Pharma gains after receiving positive USFDA EIR for Monroe Facility | 6 | capitalmarket.com | ||
| 25.11.25 | Glenmark gains after launching first-ever nebulized triple therapy for COPD | 4 | capitalmarket.com | ||
| 19.11.25 | Stocks to buy in 2025 for long term: Sun Tv, Glenmark Pharma among 5 stocks that could give 17-33% return | 4 | Times of India | ||
| 18.11.25 | Glenmark Pharma gets EC nod for acne drug Winlevi in 15 European countries | 3 | capitalmarket.com | ||
| 17.11.25 | Glenmark Pharma gains after Q2 PAT climbs 72% YoY to Rs 610 cr | 2 | capitalmarket.com | ||
| 15.11.25 | Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr | 4 | capitalmarket.com | ||
| 15.11.25 | Glenmark Pharmaceuticals Reports 72.2% Jump In Profit After Tax At Rs 610.43 Crore Due To Licensing Deal With AbbVie | 14 | The Free Press Journal | ||
| 14.11.25 | Glenmark Pharmaceuticals Ltd spurts 2.55%, gains for third straight session | 3 | capitalmarket.com | ||
| 04.11.25 | Glenmark Pharma's US subsidiary to launch 8.4% sodium bicarbonate injection in US market | 2 | capitalmarket.com | ||
| 03.11.25 | Glenmark Pharmaceuticals Ltd spurts 0.02%, rises for fifth straight session | 4 | capitalmarket.com | ||
| 30.10.25 | Glenmark Pharmaceuticals Ltd up for third consecutive session | 3 | capitalmarket.com | ||
| 30.10.25 | Import von Glenmark: Engpass: Salbutamol aus Brasilien | 3 | APOTHEKE ADHOC | ||
| 23.10.25 | Glenmark Pharma set to launch Ropivacaine Hydrochloride Injection in US | 3 | capitalmarket.com |
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SINOPHARM | 2,244 | -1,32 % | Sinopharm Group-Aktie heute gut behauptet: Aktienwert steigt (2,08 €) | Der Anteilsschein der Sinopharm Group notiert heute ein wenig fester. Zuletzt zahlten Investoren für das Wertpapier 2,08 Euro. Jahreschart der Sinopharm Group Ltd-Aktie, Stand 11.09.2025 Freuen können... ► Artikel lesen | |
| CSPC PHARMA | 1,075 | -1,96 % | CSPC PHARMA (01093): INDICATIVE RESULTS OF CSPC INNOVATION PHARMACEUTICAL CO., LTD. FOR THE YEAR ENDED 31 DECEMBER 2025 | ||
| WUXI BIOLOGICS | 4,153 | -1,07 % | Duoning Biotech Applies for HK Listing; WUXI BIO Largest Client | ||
| SHANGHAI FOSUN PHARMACEUTICAL | 2,174 | +1,30 % | Milliarden für Metsera & Fosun Pharma: Pfizers Schicksalsjahre beginnen | Die Pfizer-Aktie steht aktuell bei 21 EUR - ein Niveau, das die Unsicherheit der letzten zwei Jahre widerspiegelt. Nach dem steilen Absturz der COVID-Umsätze kämpft der Pharmariese darum, sein Portfolio... ► Artikel lesen | |
| GEDEON RICHTER | 26,320 | -2,30 % | Gedeon Richter Plc.: Voting rights, registered capital | ||
| DR REDDYS | 10,900 | -0,91 % | DR REDDYS LABORATORIES LTD - 6-K, Report of foreign issuer | ||
| ASPEN PHARMACARE | 6,250 | +5,04 % | Dividendenbekanntmachungen (01.10.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACRES COMMERCIAL REALTY CORP PFD D US00489Q3002 0,4921 USD 0,4193 EUR AECOM US00766T1007 0,26 USD 0,2215 EUR AFRICAN RAINBOW MINERALS... ► Artikel lesen | |
| SHANGHAI PHARMACEUTICALS | 1,350 | +2,27 % | Dividendenbekanntmachungen (29.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADWAYS INC JP3121970002 6,35 JPY 0,0344 EUR AGC INC JP3112000009 105 JPY 0,5701 EUR AMERICAN TOWER CORPORATION US03027X1000 1... ► Artikel lesen | |
| LUYE PHARMA | 0,306 | -1,29 % | LUYE PHARMA (02186): VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR CLASS 1 INNOVATIVE DRUG RUOXINLIN FOR THE NEW INDICATION OF GENERALIZED ANXIETY DISORDER ... | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,137 | -1,44 % | SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-NEW SPECIFICATIONS OF PLLA FILLER OF SIHUAN PHARMACEUTICAL APPROVED FOR MARKET BY NMPA | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,494 | 0,00 % | CHINARES PHARMA (03320): NOTIFICATION OF PUBLICATION OF CORPORATE COMMUNICATIONS ON THE COMPANY'S WEBSITE | ||
| HANSOH PHARMACEUTICAL | 4,380 | -1,35 % | Dividendenbekanntmachungen (22.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AECON GROUP INC CA00762V1094 0,19 CAD 0,1173 EUR APT SATELLITE HOLDINGS LTD BMG0438M1064 0,025 HKD 0,0027 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| CHINA SHINEWAY PHARMACEUTICAL GROUP | 1,080 | +4,85 % | Dividendenbekanntmachungen (09.09.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0,1348 HKD 0,0147 EUR AMEREN CORPORATION US0236081024 0,71 USD 0,6037 EUR ANHUI... ► Artikel lesen | |
| KALBE FARMA | 0,055 | +7,84 % | KLBF to buyback shares, allocating IDR 250 billion: KLBF plans to repurchase shares worth IDR 250 billion over ... | ||
| YICHANG HEC CHANGJIANG PHARMACEUTICAL | - | - | HEC CJ PHARM (01558): JOINT ANNOUNCEMENT UPDATE REGARDING CONDITIONAL PRIVATISATION OF YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. BY SUNSHINE LAKE ... |
Das Unternehmen GLENMARK PHARMACEUTICALS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLENMARK PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.